CHARACTERIZING DISEASE BURDEN IN AN ULTRA-RARE DISEASE IN THE UNITED STATES: TRANSTHYRETIN (TTR) AMYLOIDOSIS PATIENTS & CAREGIVERS

被引：4
|
作者：
Stewart, M. [1 ]
Loftus, J. [2 ]
Lenderking, W. R. [3 ]
Murphy, B. R. [3 ]
Alvir, J. [4 ]
Roberts, L. [5 ]
Shaffer, S. [5 ]
Cicchetti, M. J. [1 ]
Gleeson, S. [5 ]
机构：
[1] Pfizer Inc, Groton, CT 06340 USA
[2] Pfizer Ltd, Tadworth, Surrey, England
[3] Evidera, Lexington, MA USA
[4] Pfizer Inc, New York, NY USA
[5] Evidera, Bethesda, MD USA
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 07期
关键词：
D O I：
10.1016/j.jval.2013.08.365
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A386 / A386
页数：1
相关论文
共 50 条
  • [21] Wild-type transthyretin cardiac amyloidosis: When is a rare disease no longer a rare disease?
    Kshama Wechalekar
    Ashutosh D. Wechalekar
    Journal of Nuclear Cardiology, 2021, 28 : 2857 - 2859
  • [22] Burden of Hereditary Transthyretin Amyloidosis With Polyneuropathy in Patients Enrolled in the Phase 3 Study NEURO-TTR
    Berk, John
    Wang, Annabel K.
    Coelho, Teresa
    Cruz, Marcia Waddington
    Polydefkis, Michael J.
    Dyck, Peter J.
    Scheinberg, Morton
    Plante-Bordeneuve, Violaine
    Barroso, Fabio
    Adams, David
    Brannagan, Thomas
    Whelan, Carol
    Drachman, Brian M.
    Heitner, Stephen B.
    Conceicao, Isabel
    Schmidt, Hartmut
    Vita, Giuseppe
    Campistol, Josep M.
    Gamez, Josep
    Gane, Edward
    Gorevic, Peter
    Bulle Oliveira, Acary Souza
    Monia, Brett P.
    Hughes, Stephen G.
    Kwoh, Jesse
    McEvoy, Bradley W.
    Baker, Brenda F.
    Ackermann, Elizabeth J.
    Guthrie, Spencer
    Kessler, Asia Sikora
    Gertz, Morie
    Benson, Merrill D.
    Merlini, Giampaolo
    NEUROLOGY, 2018, 90
  • [23] Drug reduces excess iron in ultra-rare neurodegenerative disease
    Sarah Lemprière
    Nature Reviews Neurology, 2019, 15 : 492 - 493
  • [24] Drug reduces excess iron in ultra-rare neurodegenerative disease
    Lempriere, Sarah
    NATURE REVIEWS NEUROLOGY, 2019, 15 (09) : 492 - 493
  • [25] Zebrafish models ultra-rare X-linked disease
    Linda Koch
    Nature Reviews Genetics, 2014, 15 (12) : 778 - 778
  • [26] Child with ultra-rare disease gets a treatment just for her
    Nature, 2024, 632 (8026) : 711 - 711
  • [27] Establishing a Novel Reimbursement Strategy for Drugs Developed for "Angel" Ultra-Rare Disease Patients
    Horgan, Richard
    Faulkner, Eric
    MOLECULAR THERAPY, 2024, 32 (04) : 652 - 653
  • [28] Why we should care about ultra-rare disease
    Harari, Sergio
    EUROPEAN RESPIRATORY REVIEW, 2016, 25 (140): : 101 - 103
  • [29] Integrated Applied Clinical Pharmacology in the Advancement of Rare and Ultra-Rare Disease Therapeutics
    Ryder, Steven
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 116 (06) : 1485 - 1495
  • [30] Cardiovascular autonomic failure in hereditary transthyretin amyloidosis and TTR carriers is an early and progressive disease marker
    Chiaro, Giacomo
    Stancanelli, Claudia
    Koay, Shiwen
    Vichayanrat, Ekawat
    Sander, Laura
    Ingle, Gordon T.
    McNamara, Patricia
    Carr, Aisling S.
    Wechalekar, Ashutosh D.
    Whelan, Carol J.
    Gillmore, Julian D.
    Hawkins, Philip N.
    Reilly, Mary M.
    Mathias, Christopher J.
    Iodice, Valeria
    CLINICAL AUTONOMIC RESEARCH, 2024, 34 (03) : 341 - 352
12345